+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Japan Continuous Renal Replacement Therapy (CRRT) Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Thumbnail Image

Japan Continuous Renal Replacement Therapy (CRRT) Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • April 2024
  • 80 Pages
  • Japan
From
Poland Continuous Renal Replacement Therapy (CRRT) Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Thumbnail Image

Poland Continuous Renal Replacement Therapy (CRRT) Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • April 2024
  • 80 Pages
  • Poland
From
Russia Continuous Renal Replacement Therapy (CRRT) Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Thumbnail Image

Russia Continuous Renal Replacement Therapy (CRRT) Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • April 2024
  • 80 Pages
  • Russia
From
Saudi Arabia Continuous Renal Replacement Therapy (CRRT) Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Thumbnail Image

Saudi Arabia Continuous Renal Replacement Therapy (CRRT) Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • April 2024
  • 80 Pages
  • Saudi Arabia
From
Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 71 Pages
  • Global
From
Polycystic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Polycystic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 109 Pages
  • Global
From
Kidney Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Kidney Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 155 Pages
  • Global
From
Renal Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Renal Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 250 Pages
  • Global
From
Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 184 Pages
  • Global
From
Hepatitis A Virus Cellular Receptor 2 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Hepatitis A Virus Cellular Receptor 2 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 64 Pages
  • Global
From
Liver Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Liver Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 174 Pages
  • Global
From
Liver X Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Liver X Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 42 Pages
  • Global
From
Hepatitis B Virus Surface Antigen Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Hepatitis B Virus Surface Antigen Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 72 Pages
  • Global
From
Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 42 Pages
  • Global
From
P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021 - Product Thumbnail Image

P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021

  • Report
  • November 2021
  • 70 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Kidney Fibrosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Kidney Fibrosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 187 Pages
  • Global
From
US Nonalcoholic Steatohepatitis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Nonalcoholic Steatohepatitis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Renal Cell Carcinoma Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Renal Cell Carcinoma Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Hepatitis B Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Hepatitis B Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more